Trends & Strategies Shaping the $1,357.40 Million Elastomeric Infusion Pumps Market, 2025-2033 | Astute Analytica

The global elastomeric infusion pumps growth is driven by rising demand for home-based care, ambulatory treatment, and ...
Morningstar

EMED Expands VersaRate® IP Portfolio, The Global Standard in Infusion Flow Rate Control for Mechanical Pumps

NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Today, EMED Technologies, a global leader in drug delivery and infusion therapy innovation, today announced the issuance of U.S. Patent No. 12,403,243 that ...
WKRG

Recce Pharmaceuticals Announces Safety Committee Approves Faster Infusion Rate in Phase I/II Trial of RECCE® 327 for Urinary Tract Infections and Urosepsis

Independent Safety Committee approves the next cohort dosing of RECCE ® 327 (R327) at a faster infusion rate of 15 minutes of 3,000mg via intravenous (IV) administration R327 was shown to be safe and ...
KTLA

Recce Pharmaceuticals Completes Dosing First Subjects at 15-Minute Infusion Rate in a Phase I/II Trial of RECCE® 327 for Urinary Tract Infections and Urosepsis

Phase I/II study is tracking to meet primary endpoints RECCE ® 327 at 3,000mg over 15 minutes marks the fastest infusion rate of a high concentration Cohort fully recruited with remaining subjects to ...